Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
To further characterize mechanisms of glucose counterregulation in man, the effects of pharmacologically inducd deficiencies of glucagon, growth hormone, and catecholamines (alone and in combination) on recovery of plasma glucose from insulin-induced hypoglycemia and attendant changes in isotopically ([3-(3)H]glucose) determined glucose fluxes were studied in 13 normal subjects. In control studies, recovery of plasma glucose from hypoglycemia was primarily due to a compensatory increase in glucose production; the temporal relationship of glucagon, epinephrine, cortisol, and growth hormone responses with the compensatory increase in glucose appearance was compatible with potential participation of all these hormones in acute glucose counterregulation. Infusion of somatostatin (combined deficiency of glucagon and growth hormone) accentuated insulin-induced hypoglycemia (plasma glucose nadir: 36+/-2 ng/dl during infusion of somatostatin vs. 47+/-2 mg/dl in control studies, P < 0.01) and impaired restoration of normoglycemia (plasma glucose at min 90: 73+/-3 mg/dl at end of somatostatin infusion vs. 92+/-3 mg/dl in control studies, P<0.01). This impaired recovery of plasma glucose was due to blunting of the compensatory increase in glucose appearance since glucose disappearance was not augmented, and was attributable to suppression of glucagon secretion rather than growth hormone secretion since these effects of somatostatin were not observed during simultaneous infusion of somatostatin and glucagon whereas infusion of growth hormone along with somatostatin did not prevent the effect of somatostatin. The attenuated recovery of plasma glucose from hypoglycemia observed during somatostatin-induced glucagon deficiency was associated with plasma epinephrine levels twice those observed in control studies. Infusion of phentolamine plus propranolol (combined alpha-and beta-adrenergic blockade) had no effect on plasma glucose or glucose fluxes after insulin administration. However, infusion of somatostatin along with both phentolamine and propranolol further impaired recovery of plasma glucose from hypoglycemia compared to that observed with somatostatin alone (plasma glucose at end of infusions: 52+/-6 mg/dl for somatostatin-phentolamine-propranolol vs. 72+/-5 mg/dl for somatostatin alone, P < 0.01); this was due to further suppression of the compensatory increase in glucose appearance (maximal values: 1.93+/-0.41 mg/kg per min for somatostatin-phentolamine-propranolol vs. 2.86+/-0.32 mg/kg per min for somatostatin alone, P < 0.05). These results indicate that in man (a) restoration of normoglycemia after insulin-induced hypoglycemia is primarily due to a compensatory increase in glucose production; (b) intact glucagon secretion, but not growth hormone secretion, is necessary for normal glucose counterregulation, and (c) adrenergic mechanisms do not normally play an essential role in this process but become critical to recovery from hypoglycemia when glucagon secretion is impaired.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,680
Zar, J. H. (1996) · Cited by 7,837
MURPHY, B. E. P. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-7-973 · Cited by 1,994
Hypoglycemia: A Potent Stimulus to Secretion of Growth Hormone
Roth, J., Glick, S. M., Yalow, R. S., & Berson, S. A. (1963) · Science · doi:10.1126/science.140.3570.987 · Cited by 669
Neural control of the endocrine pancreas.
Woods, S. C., & Porte, D. (1974) · Physiological Reviews · doi:10.1152/physrev.1974.54.3.596 · Cited by 630
ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.
DeBodo, R. C., Steele, R., ALTSZULER, N., Dunn, A., & Bishop, J. (1963) · PubMed · Cited by 532
Tissue effects of glucocorticoids
Baxter, J. D., & Forsham, P. H. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90154-4 · Cited by 503
The Control of Glycogen Metabolism in the Liver
Hers, H. G. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.001123 · Cited by 448
The control of glycogen metabolism in the liver
Hers, H. G., De Wulf, H., & Stalmans, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80569-5 · Cited by 414
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citation
Cited by
Items 201–300 of 420
Counterregulatory Hormones during Moderate, Insulin-Induced, Blood Glucose Decrements in Man*
Santeusanio, F., Bolli, G. B., Massi‐Benedetti, M., Feo, P. D., Angeletti, G., Compagnucci, P., Calabrese, G., & Brunetti, P. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-3-477 · Cited by 23
Patel, D. G. (1984) · Metabolism · doi:10.1016/0026-0495(84)90098-2 · Cited by 19
Brehm, A., Thomaseth, K., Bernroider, E., Nowotny, P., Waldhäusl, W. K., Pacini, G., & Roden, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0019 · Cited by 22
Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation
El-Tayeb, K. M. A., Brubaker, P. L., Lickley, H. L. A., Cook, E. H., & Vranić, M. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.3.e236 · Cited by 22
�rskov, L., Bak, J. F., Abildg�rd, N., Schmitz, O., Andreasen, F., Richter, E. A., Skj�rb�k, C., & M⊘ller, N. (1996) · Diabetologia · doi:10.1007/bf00403967 · Cited by 22
“In studies involving short-term and more prolonged insulin infusion as well as the pituitary-adrenal-pancreatic-clamp technique [7-10] the present concept of hypoglycaemic counter-regulation has emerged; within minutes of lowering the plasma glucose level the combined effects of suppressed endogenous insulin secretion…”
BackgroundAttvall, S., Fowelin, J., von Schenck, H., Lager, I., & Smith, U. (1987) · Diabetologia · doi:10.1007/bf00296990 · Cited by 23
“Glucagon is of major importance for glucose counter-regulation during hypoglycaemia [2, 3 ]. However, the release of this hormone is impaired in Type 1 diabetic patients; this is one important reason for the slower glucose recovery in these patients [26, 27].”
BackgroundTargeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes
Panzer, J. K., & Caicedo, A. (2021) · Diabetes · doi:10.2337/dbi20-0048 · Cited by 22
Struthers, A. D., Whitesmith, R., & Reid, J. L. (1983) · Heart · doi:10.1136/hrt.50.3.277 · Cited by 20
Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs
Davis, S. N., Dobbins, R. L., Colburn, C. A., Tarumi, C., Jacobs, J. K., Neal, D. W., & Cherrington, A. D. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.5.e748 · Cited by 24
The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans
Feo, P. D., Perriello, G., Ventura, M. M., Brunetti, P., Santeusanio, F., Gerich, J. E., & Bolli, G. B. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.4.e565 · Cited by 24
Self-citationHerbel, G., & Boyle, P. J. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70161-4 · Cited by 24
Adamson, U. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb02048.x · Cited by 21
Capaldo, B., Napoli, R., Guida, R., Bonito, P. D., Antoniello, S., Auletta, M., Pardo, F., Rendina, V., & Saccà, L. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.2.e248 · Cited by 20
DOEDEN, B., & Rizza, R. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-902 · Cited by 22
Self-citationService, F. J. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70288-7 · Cited by 21
Heller, S. R. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0020 · Cited by 24
Acute hypoglycemia in man: Neural control of pancreatic islet cell function
Corrall, R. J. M., & Frier, B. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90166-9 · Cited by 20
Diagnosis and treatment of ‘insulinoma’
Fajans, S. S., & Vinik, A. I. (1984) · Cancer treatment and research · doi:10.1007/978-1-4613-2849-0_11 · Cited by 22
Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus
Perriello, G., Misericordia, P., Volpi, E., Pampanelli, S., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629243 · Cited by 21
Widmaier, E. P., Shah, P. R., & Lee, G. A. (1991) · Regulatory Peptides · doi:10.1016/0167-0115(91)90182-g · Cited by 19
Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes
Halama, A., Kahal, H., Bhagwat, A. M., Zierer, J., Sathyapalan, T., Graumann, J., Suhre, K., & Atkin, S. L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13602 · Cited by 20
Huang, T., Huang, S. ‐., & Hsu, M. M. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03349671 · Cited by 18
THE ACE-INHIBITOR LISINOPRIL AFFECTS PLASMA INSULIN LEVELS BUT NOT FIBRINOLYTIC PARAMETERS
Zehetgruber, M., Beckmann, R., Gabriel, H., Christ, G., Binder, B. R., & Huber, K. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)00115-6 · Cited by 18
Ipp, E., Sinai, Y., FORSTER, B., Cortez, C., Bar‐Oz, B., Nesher, R., & Cerasi, E. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-711 · Cited by 17
Schopman, J. E., Hoekstra, J. B. L., Frier, B. M., Ackermans, M. T., de Sonnaville, J. J. J., Stades, A. M. E., Zwertbroek, R., Hartmann, B., Holst, J. J., Knop, F. K., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12453 · Cited by 17
Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
(1984) · PubMed Central · Cited by 17
Hypoglycemia and embryonic heart development
Smoak, I. W. (2002) · Frontiers in bioscience · doi:10.2741/a776 · Cited by 18
“Other counter-regulatory hormones, such as epinephrine, growth hormone, and cortisol, are thus activated to correct insulin-induced hypoglycemia (32-33).”
BackgroundGlucagon Responses to Hypoglycemia in Children and Adolescents With IDDM
Singer-Granick, C. J., Hoffman, R. P., Kerensky, K. M., DRASH, A. L., & Becker, D. J. (1988) · Diabetes Care · doi:10.2337/diacare.11.8.643 · Cited by 19
“As the glucagon response to hypoglycemia wanes, adrenergic mechanisms take on an increasingly important role in the return to euglycemia after a hypoglycemic episode (1,6,8,11,16-20).”
BackgroundInsulin‐antagonistic effects of counterregulatory hormones: Clinical and mechanistic aspects
Smith, U., & Lager, I. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050604 · Cited by 19
Pathophysiology and management of hypoglycemia in diabetes
RANGEL, E. S., Deajon-Jackson, J. D., & Hwang, J. J. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14904 · Cited by 21
Abderrahman, A. B., Rhibi, F., Ouerghi, N., Hackney, A. C., Saeidi, A., & Zouhal, H. (2018) · Journal of Athletic Enhancement · doi:10.4172/2324-9080.1000292 · Cited by 24
Aitken, M. L., Szkudlinska, M. A., Boyko, E. J., Ng, D. M., Utzschneider, K. M., & Kahn, S. E. (2020) · Diabetologia · doi:10.1007/s00125-020-05096-6 · Cited by 18
“The counterregulatory response to hypoglycaemia has been well studied under experimental clamp conditions with insulininduced hypoglycaemia [16, 17].”
BackgroundHvidberg, A., Rasmussen, M. H., Christensen, N. J., & Hilsted, J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90130-9 · Cited by 17
Plasma Levels of Catecholamines and Dopamine-β-Hydroxylase
Kopin, I. J. (1989) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-73551-6_6 · Cited by 29
Counterregulatory hormones oscillate during steady-state hypoglycemia
Genter, P. M., Berman, N., Jacob, M., & Ipp, E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e821 · Cited by 18
Franz, I.-W., & Lohmann, F. W. (1980) · Journal of Molecular Medicine · doi:10.1007/bf01477238 · Cited by 18
Heptulla, R. A., Tamborlane, W. V., Y.-Z., T., Rife, F., & Sherwin, R. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7198 · Cited by 15
Guerci, B., Kuhn, J., Larger, É., & Reznik, Y. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.05.002 · Cited by 12
Prevention of recurrent hypoglycemia in type 1 diabetes by pancreas transplantation
Robertson, R. P. (1999) · Acta Diabetologica · doi:10.1007/s005920050138 · Cited by 17
“The normal acute defense mechanisms against insulininduced hypoglycemia consist primarily of glucagon release from the α-cells of the pancreatic islet followed shortly thereafter by epinephrine release from the adrenal medulla [ 1 ].”
BackgroundHypoglycemic glucose counterregulation in patients with insulin-dependent diabetes mellitus.
Cryer, P. E. (1982) · PubMed · Cited by 18
Self-citationSelective suppression of hepatic glucose output by human proinsulin in the dog
Lavelle-Jones, M., Scott, M. H., Kolterman, O., Rubenstein, A. H., Olefsky, J. M., & Moossa, A. R. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.2.e230 · Cited by 14
Justice, T. D., Hammer, G. L., Davey, R. J., Paramalingam, N., Guelfi, K. J., Lewis, L. K., Davis, E. A., Jones, T. W., & Fournier, P. A. (2015) · Physiological Reports · doi:10.14814/phy2.12386 · Cited by 15
“The increase in catecholamines may also stimulate glucose Ra, with both epinephrine and norepinephrine associated with increased rates of hepatic glucose production (Rizza et al. 1979; Purdon et al. 1993; Kreisman et al. 2000, 2001, 2003).”
BackgroundAbnormal Glucose Counterregulation in Insulin-Dependent Diabetes Mellitus
(1984) · New England Journal of Medicine · doi:10.1056/nejm198410113111512 · Cited by 14
Effect of Stress on Glucoregulation in Physiology and Diabetes
Vranić, M., Miles, P. D. G., Rastogi, K. S., Yamatani, K., Shi, Z. Q., Lickley, L. A., & Hetenyi, G., Jr. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5931-9_13 · Cited by 16
RIZZA, R. A., Go, V. W., Cryer, P., Verdonk, C. A., & Gerich, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-6-1234 · Cited by 13
Self-citationToso, C. F. R., Rodríguez, R. R., Renauld, A., Márquez, A., & Linares, L. M. (1993) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03009482 · Cited by 13
Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus
Feo, P. D., Bolli, G. B., Lavielle, R., & Gregoris, P. D. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090507 · Cited by 14
The kinetics of glucagon action on the liver during insulin-induced hypoglycemia
Pedersen, C., Kraft, G., Edgerton, D. S., Scott, M. F., Farmer, B., Smith, M. S., LaNeve, D. C., Williams, P. E., Moore, L. M., & Cherrington, A. D. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00466.2019 · Cited by 15
Lechín, F. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s7606 · Cited by 15
“In addition, this binomial peripheral crosstalk is modulated by several physiological factors which include both peripheral neuroendocrine and central nervous system (CNS) mechanisms.(6,7) However, this physiological stability can be disrupted by many stressor factors such as exercise and restraint,(8,9) neuropharmaco…”
Sjöberg, S., Ahrén, B., & Bolinder, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01043.x · Cited by 13
Adrenergic blockade and hypoglycaemia
Lager, I. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb01615.x · Cited by 14
Glucose counterregulation during recovery from neuroglucopenia: Which mechanism is important?
Asplin, C. M., Raghu, P., Koerker, D. J., & Palmer, J. P. (1985) · Metabolism · doi:10.1016/0026-0495(85)90053-8 · Cited by 13
Horie, H., Matsuyama, T., Namba, M., ITOH, H., Nonaka, K., Tarui, S., Yamatodani, A., & Wada, H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1193 · Cited by 14
Autonomic Nervous System Control of Glucagon Secretion during Neuroglucopenia*
Asplin, C. M., Werner, P. L., Halter, J. B., Hollander, P., & Palmer, J. P. (1983) · Endocrinology · doi:10.1210/endo-112-5-1585 · Cited by 12
Lickley, H. L. A., Kemmer, F. W., Wasserman, D. H., & Vranić, M. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_16 · Cited by 14
Hypoglycaemia unawareness in insulin‐dependent diabetes mellitus
Veneman, T. F., & van Haeften, T. W. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02020.x · Cited by 13
Fasting energy utilization in the smaller of twins with epinephrine-deficient hypoglycemia
Kerr, D. S., BROOKE, O. G., & Robinson, H. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90212-2 · Cited by 12
Rizza, R. A., Westland, R. E., Hall, L. D., Patton, G. S., Haymond, M. W., Clemens, A. H., Gerich, J. E., & Service, F. J. (1981) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(26)01483-7 · Cited by 23
Self-citationPotential approaches to prevent hypoglycemia-associated autonomic failure
Lontchi-Yimagou, E., You, J. Y., Carey, M., Gabriely, I., Shamoon, H., & Hawkins, M. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000582 · Cited by 12
Lee, S., Oh, S.-H., Park, K.-Y., Park, B.-H., Kim, J., & Kim, S. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2007.0000 · Cited by 12
Connolly, C. C., Ivy, R., Adkins-Marshall, B. A., Dobbins, R. L., Neal, D. W., Williams, P. E., & Cherrington, A. D. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01212-0 · Cited by 12
Forst, T. M., Pfiutzner, A., Jahn, C., Schmitz, H., LICHTWALD, K., Beyer, J., & Lehnert, H. (1996) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(96)00029-x · Cited by 11
The Metabolic Clearance Rate of Glucagon
Polonsky, K. S., Jaspan, J. B., & Rubenstein, A. H. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_17 · Cited by 12
Spontaneous and iatrogenic hypoglycemia in cystic fibrosis
Hicks, R. A., Marks, B. E., Oxman, R., & Moheet, A. A. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100267 · Cited by 15
Anaesthesia and changes in parameters that reflect glucose metabolism in pigs – a pilot study
Manell, E., Jensen‐Waern, M., & Hedenqvist, P. (2016) · Laboratory Animals · doi:10.1177/0023677216682773 · Cited by 11
Kollind, M., Adamson, U., Lins, P., & Curstedt, T. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb15781.x · Cited by 11
Schneiter, P., Pasche, O., Vetta, V. D., Jéquier, E., & Tappy, L. (1994) · European Journal of Applied Physiology · doi:10.1007/bf00239875 · Cited by 13
Starke, A. A. R., Valverde, I., Bottazzo, G. F., Tsotsalas, M., & Zimmermann, H. (1983) · Diabetologia · doi:10.1007/bf00253197 · Cited by 11
“The fundamental role of glucagon in glucose recovery from insulin-induced hypoglycaemia has been assessed in studies with pharmacological inhibition of glucagon [ 10 ] but glucagon deficiency has not been verified by chromatography.”
BackgroundRole of counterregulatory hormones in the regulation of hepatic glucose metabolism
Saccà, L. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030110 · Cited by 12
Hormonal response to insulin-induced hypoglycemia in patients with Shy-Drager syndrome
Sasaki, K., Matsuhashi, A., Murabayashi, S., Aoyagi, K., Baba, T., Matsunaga, M., & Takebe, K. (1983) · Metabolism · doi:10.1016/0026-0495(83)90138-5 · Cited by 11
Tissue-Specific GHR Knockout Mice: An Updated Review
Nagarajan, A., Srivastava, H. K., Jablonsky, J., & Sun, L. Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.579909 · Cited by 9
“GH disruption in also the SF1 cells was found to Frontiers in Endocrinology | www.frontiersin.org 4 impair CRR initiated in response to 2DG infusion, which might be mediated through the parasympathetic nervous system.”
BackgroundInfluentialChap, Z., Ishida, T., Chou, J., Michael, L., Hartley, C. J., Entman, M. L., & Field, J. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112441 · Cited by 10
Influence of Infused Hypertonic Saline on the Response to Insulin-Induced Hypoglycemia in Man*
Adler, G. K., & Majzoub, J. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-116 · Cited by 10
Hypoglycemia and embryonic heart development
Ida, W. S. (2002) · Frontiers in bioscience · doi:10.2741/smoak · Cited by 10
Primary Hyperepinephrinemia in Patients Without Pheochromocytoma
Streeten, D. H. P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390190160028 · Cited by 11
Rizza, R. A., & Gerich, J. E. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31769-2 · Cited by 10
Self-citationCorrection for the Effect of Rising Plasma Glucose Levels on Quantification of MR glc with FDG-PET
Dunn, J., Anthony, K., Amiel, S. A., & Marsden, P. K. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.21 · Cited by 12
“It is well known that hypoglycemia can trigger counterregulatory responses that are associated with changes in cerebral neuronal activation (Rizza et al, 1979 and Mitrakou et al, 1991).”
BackgroundGlucagon and Glucose Counterregulation
Cryer, P. E. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_9 · Cited by 11
Self-citationFisher, B. M., Hepburn, D. A., Smith, J. G., & Frier, B. M. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01790.x · Cited by 9
Treatment with .ALPHA.-Glucosidase Inhibitor for Severe Reactive Hypoglycemia. A Case Report.
Teno, S., Nakajima-Uto, Y., Nagai, K., Shimizu-Saitoh, M., OZU, H., Omori, Y., & TAKIZAWA, T. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.437 · Cited by 9
Szepietowska, B., Zhu, W., & Sherwin, R. S. (2013) · Diabetologia · doi:10.1007/s00125-013-3009-7 · Cited by 11
“Together these responses result in increased endogenous glucose production, reduced tissue glucose use and reduced generation of hypoglycaemia-related symptoms [3, 4].”
Glucoregulatory hormone influence on hepatic glucose production in the elderly
Barzilai, N., Stessman, J., Cohen, P., Morali, G., Barzilai, D. A., & Karnieli, E. (1989) · AGE · doi:10.1007/bf02432513 · Cited by 10
The effect of genetically engineered glucagon on glucose recovery after hypoglycaemia in man.
HVIDBERG, A. D., Jørgensen, F. S., & Hilsted, J. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb05660.x · Cited by 9
“, 1978) were analyzed as previously described and activity of 3-[3H]-glucose was assayed according to Rizza et al. (1979). Glucose appearance rate and glucose disappearance rate were calculated using Steele's equations (Steele, 1959) modified by De Bodo et al. (1963). Specific activities of [3H]-glucose and plasma glu…”
BackgroundMethodInfluentialAdrenergic modulation of interdigestive pancreatic secretion in humans
Layer, P., Chan, A., Go, V. L. W., Zinsmeister, A. R., & DiMagno, E. P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90033-u · Cited by 10
Effects of Somatostatin and Adrenergic Blockade on Glucagon, Insulin and Glucose in Exercising Sheep
Brockman, R. P., & Halvorson, R. (1981) · Australian Journal of Biological Sciences · doi:10.1071/bi9810551 · Cited by 12
Myers, B. A., Mendoza, S. P., & Cornelius, C. E. (1988) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1988.tb00382.x · Cited by 9
Amiel, S. A. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090103 · Cited by 9
Alghothani, N., & Dungan, K. M. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0026 · Cited by 14
Effect of local sympathetic blockade on forearm blood flow and glucose uptake during hypoglycemia
Hoffman, R. P., Sinkey, C. A., & Tsalikian, E. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90248-2 · Cited by 8
NAKAMURA, T., Takebe, K., Kudoh, K., Ishii, M., Imamura, K., Kikuchi, H., Kasai, F., Tandoh, Y., Yamada, N., Arai, Y., et al. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.174.305 · Cited by 8
Lins, P., Adamson, U., Clausen, N., Hamberger, B., & Efendić, S. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02728.x · Cited by 9
Ito, K., Hirose, H., Kido, K., Koyama, K., Maruyama, H., & Saruta, T. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01189-7 · Cited by 8
Cryer, P. E. (1983) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027310-2.50025-6 · Cited by 8
Self-citationLager, I., von Schenck, H., & Smith, U. (1984) · Diabetologia · doi:10.1007/bf00266033 · Cited by 9
“Glucagon [6] and catecholamines [7, 8] have”
BackgroundRizza, R. A., Haymond, M. W., & Gerich, J. E. (1982) · Metabolism · doi:10.1016/0026-0495(82)90053-1 · Cited by 8
Self-citationKollind, M., Adamson, U., Lins, P. E., & Hamberger, B. (1988) · Diabetologia · doi:10.1007/bf00264767 · Cited by 7
“The infusion of adrenaline yielded a plasma adrenaline profile similar to that seen during insulin-induced hypoglycaemia [1] and exerted a diabetogenic effect which was, however, not demonstrable 4.”
BackgroundTao, Y., & Liang, X. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00001-6 · Cited by 8
Hoffman, E. G., D’Souza, N. C., Aiken, J., ATHERLEY, S. C., Liggins, R., & Riddell, M. C. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15002 · Cited by 9
“the development of hypoglycaemia by mobilizing glucose from the liver.(1) In type 1 diabetes (T1D), the counterregulatory glucagon response is typically absent within a few years of diagnosis, predisposing affected individuals to insulin-induced hypoglycaemia.”
BackgroundCoate, K. C., Ramnanan, C. J., Smith, M., Winnick, J. J., Kraft, G., Irimia-Dominguez, J., Farmer, B., Donahue, E. P., Roach, P. J., Cherrington, A. D., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00316.2023 · Cited by 7
“3 Introduction 45 Stimulation of hepatic glucose production (HGP) by glucagon is critical to the regulation of 46 glucose homeostasis during fasting (62), exercise (63), trauma and infection (53), and hypoglycemia 47 (8, 47, 50).”
BackgroundMeek, T. H., Matsen, M. E., Faber, C. L., Samstag, C. L., Damian, V. M., Hồng, N. T., Scarlett, J. M., Flak, J. N., Myers, M. G., & Morton, G. J. (2018) · Endocrinology · doi:10.1210/en.2017-03199 · Cited by 7
Metadata
- Authors
- Rizza, R. A., Cryer, P. E., & Gerich, J. E.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1979-07-01
- Volume
- 64
- Issue
- 1
- Pages
- 62-71
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC372091
- OpenAlex
- W1600232156
- Semantic Scholar
- 11f4079b84a608bc5984f3e84f9d0ccc73640319
- Cited by
- 421
- References
- 53
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 12 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 11 · 2012: 3
- FWCI
- 32.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- glucose counterregulation, insulin-induced hypoglycemia, glucagon, growth hormone, catecholamines, epinephrine, somatostatin, glucose appearance, glucose disappearance, glucose production, cortisol, adrenergic blockade, phentolamine, propranolol, glucose flux, glucagon deficiency, growth hormone deficiency
- MeSH terms
- Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Adult, Blood Glucose, Catecholamines, Drug Interactions, Female, Glucagon, Humans, Hypoglycemia, Insulin, Male, Middle Aged, Phentolamine, Propranolol, Somatostatin, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.